Gelteq (GELS) Free Cash Flow (2024)
Gelteq (GELS) recorded quarterly Free Cash Flow of -$2.4 million in Q4 2024.
Gelteq (GELS) Free Cash Flow (2024) Analysis & Trends
Gelteq's Free Cash Flow history runs 1 years deep, the most recent figure standing at -$2.4 million for Q4 2024.
- In Q4 2024, Free Cash Flow changed N/A year-over-year to -$2.4 million; the TTM figure through Jun 2025 stood at -$2.4 million (changed N/A YoY), while the FY2025 annual figure was -$3.5 million, down 400.07% from the prior year.
- Free Cash Flow was -$2.4 million for Q4 2024 at Gelteq.
- In the past five years, Free Cash Flow ranged from a high of -$2.4 million in Q4 2024 to a low of -$2.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Gelteq | 10.57 Mn | 10.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.35 Mn |
| Dec 31, 2024 | -2.35 Mn |